ONCO - Oncopeptides AB Dividends StockRank™ Dividends made by Oncopeptides AB from their annual profits to their shareholders are shown here

On Wednesday, Oncopeptides AB (ONCO:STO) closed at 152.20, -29.21% below its 52-week high of 215.00, set on Mar 01, 2021.

Shares in Oncopeptides AB are currently priced at SEK160. At that level they are trading at 48.19% discount to the analyst consensus target price of 0.00. Analysts covering Oncopeptides AB currently have a consensus Earnings Per Share (EPS) forecast of -19.54 for the next financial year. US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies. Oncopeptides AB (publ) (ONPPF) Stock Price History | wallmine Compiled here, all relevant comments and discussions regarding the ONCO Stock. Compiled here, Oncopeptides AB (ONCO) Stockholm. Create Alert.

Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Oncopeptides hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser. Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on Stockholm Stock Exchange in Sweden.. The public information regarding Oncopeptides AB's current market price is not available at this time.

Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series

Compiled here, all relevant comments and discussions regarding the ONCO Stock. Compiled here, Oncopeptides AB (ONCO) Stockholm.

Stockwik Förvaltning, +7,96% Oncopeptides, -1,85%, 73 366 453 AIFM Capital, Aktia Rahastoyhtiö Oy, Aktie-Ansvar, Alcur Fonder AB, Alfakraft Fonder AB

Every day we are inspired by the perseverance that we see from patients, care givers and health care providers in their fight against cancer. Sedan 1997 har vi hjälpt våra kunder att göra vinstgivande aktieaffärer. Här hittar du färska aktietips, intervjuer, aktieanalyser och det senaste från aktiemarknaden. Find out if ONPPF (PINX) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on ONPPF.

US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies.
Verfalldatum перевод

Welcome to Oncopeptides, Inc. At Oncopeptides we are committed to the development of therapies for difficult-to-treat hematological diseases. We strive to bring hope to patients through science and innovation.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. On Wednesday, Oncopeptides AB (ONCO:STO) closed at 152.20, -29.21% below its 52-week high of 215.00, set on Mar 01, 2021. Shares in Oncopeptides AB are currently priced at SEK160. At that level they are trading at 48.19% discount to the analyst consensus target price of 0.00.
Lediga jobb folkhogskola

31 Mar 2021 Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday. It's eyeing a new buy point. VIVO stock has risen as much as 456%

The company, which is listed on the Stockholm Stock Exchange, was founded in Sweden year 2000 and operates globally. Oncopeptides develops drugs for the treatment of cancer/hematology and is in a very exciting phase of development.

Ey revision sønderborg

A high-level overview of ONCOPEPTIDES AB AK (ONPPF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

STOCKHOLM — 9 december 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), ett läkemedelsbolag inriktat på utvecklingen av riktade behandlingar för svårbehandlade hematologiska sjukdomar, meddelar idag att resultaten från den registreringsgrundande fas 2-studien HORIZON, som utvärderar intravenöst melflufen (INN melphalan flufenamide) i kombination med dexametason i patienter med relapserande och refraktärt multipelt myelom, har publicerats i den vetenskapliga tidskriften ONCOPEPTIDES AB E:ONCOS - Turquoise is the European Multilateral Trading Facility (MTF) majority owned by London Stock Exchange Group in partnership with the user community, providing members a single connection to trade securities from 19 European and emerging markets as well as US stocks, IOB Depositary Receipts, ETFs and European Rights Issues Oncopeptides AB, ONCO: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short You are now leaving the global website of Oncopeptides AB, Sweden.

Oncopeptides AB. kr 156.60-2.97%. BioInvent International AB. kr 46.50-1.27%. Cantargia AB. kr 28.85-1.87%. Stora Enso Ord Shs Class R.

Electrolux AB Class B. kr 251.00+2.16%. RaySearch Laboratories AB (publ). kr 91.50+0.55%. Electrolux Oncopeptides värdering är fullstretchad.

Risk Analysis. View today's stock price, news and analysis for Oncopeptides AB (ONCO).